阿德福韦双异戊酰氧甲酯 (Adefovirdipivoxil ,简称ADV )是一种新的抗乙型肝炎病毒 (HBV)的药物。 2 0 0 2年 9月经美国食品药物管理局 (FDA)批准在美国上市 ,是继拉米夫定后的另一个口服抗HBV药物。ADV属单磷酸腺苷磷酸核苷酸类似物 ,其化学名是 :9 [ 2 [[双·[三甲基乙酰氧 ) Adefovirdipivoxil (ADV) is a new anti-hepatitis B virus (HBV) drug. In September 2002, it was approved by the U.S. Food and Drug Administration (FDA) for listing in the United States. It is another oral anti-HBV drug following lamivudine. ADV is an adenosine monophosphate nucleotide analog that has the chemical name: 9 [2 [[bis [trimethylacetoxy)